Next 10 |
Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse” or the “Company”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced that the Company’s Board of Directors has set the ...
2024-04-25 21:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024. Company ...
2024-04-04 10:00:40 ET More on Pulse Biosciences Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript Pulse Biosciences to initiate rights offering Financial information for Pulse Biosciences Read the full article on Seeking Alpha For further...
2024-04-01 10:00:18 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...
2024-03-28 20:52:08 ET Pulse Biosciences Inc (PLSE) Q4 2023 Results Conference Call March 28, 2024 4:30 PM ET Company Participants Philip Taylor - IR Kevin Danahy - President & CEO Darrin Uecker - CTO & Director Mitch Levinson - Chief Strategy Officer...
2024-03-28 17:18:32 ET More on Pulse Biosciences Pulse Biosciences to initiate rights offering Pulse Biosciences submits market application for cardiac ablation device Financial information for Pulse Biosciences Read the full article on Seeking Alpha ...
2024-03-28 16:48:12 ET More on Pulse Biosciences Pulse Biosciences submits market application for cardiac ablation device Financial information for Pulse Biosciences Read the full article on Seeking Alpha For further details see: Pulse Biosciences to init...
2024-03-28 16:14:09 ET More on Pulse Biosciences Pulse Biosciences submits market application for cardiac ablation device Financial information for Pulse Biosciences Read the full article on Seeking Alpha For further details see: Pulse Biosciences GAAP EP...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31, 2023. Recen...
News, Short Squeeze, Breakout and More Instantly...
Pulse Biosciences Inc Company Name:
PLSE Stock Symbol:
NASDAQ Market:
Pulse Biosciences Inc Website:
Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse” or the “Company”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced that the Company’s Board of Directors has set the ...
2024-04-25 21:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024. Company ...